We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Indiana University Dementia Screening Trial
Updated: 12/31/1969
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
Indiana University Dementia Screening Trial
Updated: 12/31/1969
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Indiana University Dementia Screening Trial
Updated: 12/31/1969
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
Indiana University Dementia Screening Trial
Updated: 12/31/1969
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Indiana University Dementia Screening Trial
Updated: 12/31/1969
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
Indiana University Dementia Screening Trial
Updated: 12/31/1969
Indiana University Dementia Screening Trial: The IU CHOICE Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
EKSO Trial: Powered Exoskeleton for Ambulation in Subjects With Spinal Cord Injury (SCI)
Updated: 12/31/1969
Investigational Study of the Ekso Powered Exoskeleton for Ambulation in Individuals With Spinal Cord Injury (or Similar Neurological Weakness)
Status: Enrolling
Updated: 12/31/1969
EKSO Trial: Powered Exoskeleton for Ambulation in Subjects With Spinal Cord Injury (SCI)
Updated: 12/31/1969
Investigational Study of the Ekso Powered Exoskeleton for Ambulation in Individuals With Spinal Cord Injury (or Similar Neurological Weakness)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurofeedback for Tourette Syndrome
Updated: 12/31/1969
Neurofeedback of Activity in the Supplementary Motor Area for Tourette Syndrome
Status: Enrolling
Updated: 12/31/1969
Neurofeedback for Tourette Syndrome
Updated: 12/31/1969
Neurofeedback of Activity in the Supplementary Motor Area for Tourette Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Updated: 12/31/1969
Thrombolysis in Pediatric Stroke (TIPS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Comparison of Propofol Versus Midazolam to Sedate Critically Brain Injury; Measurement of Cytokine Response and Assessment of Function
Updated: 12/31/1969
Propofol Versus Midazolam for Sedation in Mechanically Ventilated Critically Ill Patients Who Presented With Traumatic Brain Injury: Cytokine Response and Neuropsychological Assessment (IRRC#1201M)
Status: Enrolling
Updated: 12/31/1969
A Comparison of Propofol Versus Midazolam to Sedate Critically Brain Injury; Measurement of Cytokine Response and Assessment of Function
Updated: 12/31/1969
Propofol Versus Midazolam for Sedation in Mechanically Ventilated Critically Ill Patients Who Presented With Traumatic Brain Injury: Cytokine Response and Neuropsychological Assessment (IRRC#1201M)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Updated: 12/31/1969
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
Updated: 12/31/1969
Efficacy of Intravenous Levetiracetam in Neonatal Seizures: A Phase 2 Randomized Blinded Controlled Study of the Efficacy of Intravenous Levetiracetam (LEV) as First Line Treatment for Neonatal Seizures
Status: Enrolling
Updated: 12/31/1969
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
Updated: 12/31/1969
Efficacy of Intravenous Levetiracetam in Neonatal Seizures: A Phase 2 Randomized Blinded Controlled Study of the Efficacy of Intravenous Levetiracetam (LEV) as First Line Treatment for Neonatal Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
Updated: 12/31/1969
Estrogen Receptor-beta phytoSERMs for Management of Menopause and Age-Associated Memory Decline
Status: Enrolling
Updated: 12/31/1969
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
Updated: 12/31/1969
Estrogen Receptor-beta phytoSERMs for Management of Menopause and Age-Associated Memory Decline
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy
Updated: 12/31/1969
Treatment of Post-TBI Fatigue With Light Therapy
Status: Enrolling
Updated: 12/31/1969
Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy
Updated: 12/31/1969
Treatment of Post-TBI Fatigue With Light Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Examining How Motor Rehabilitation Promotes Brain Reorganization Following Stroke, an MRI Study
Updated: 12/31/1969
Examining Mechanisms of Neuroplasticity Following Motor Rehabilitation in Stroke
Status: Enrolling
Updated: 12/31/1969
Examining How Motor Rehabilitation Promotes Brain Reorganization Following Stroke, an MRI Study
Updated: 12/31/1969
Examining Mechanisms of Neuroplasticity Following Motor Rehabilitation in Stroke
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Role of Ipsilateral Motor Cortex in Executing Movements With Increasing Demand on Precision
Updated: 12/31/1969
Enhancing Stroke Recovery Through Cortical Stimulation: The Role of the Ipsilateral Motor Cortex in Executing Movements With Increasing Demand on Precision
Status: Enrolling
Updated: 12/31/1969
Role of Ipsilateral Motor Cortex in Executing Movements With Increasing Demand on Precision
Updated: 12/31/1969
Enhancing Stroke Recovery Through Cortical Stimulation: The Role of the Ipsilateral Motor Cortex in Executing Movements With Increasing Demand on Precision
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Robots Paired With tDCS in Stroke Recovery
Updated: 12/31/1969
Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients
Status: Enrolling
Updated: 12/31/1969
Robots Paired With tDCS in Stroke Recovery
Updated: 12/31/1969
Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy
Updated: 12/31/1969
An Open-label, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Subjects Aged 16 Years or Older With Epilepsy Phase 3b
Status: Enrolling
Updated: 12/31/1969
Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy
Updated: 12/31/1969
An Open-label, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Subjects Aged 16 Years or Older With Epilepsy Phase 3b
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials